Bevacizumab increases toxicity, VTE in bladder cancer: Commentary
Publication
, Journal Article
Armstrong, AJ
Published in: Oncology Report
September 1, 2009
Duke Scholars
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2009
Issue
FALL
Start / End Page
24
Related Subject Headings
- Oncology & Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Armstrong, A. J. (2009). Bevacizumab increases toxicity, VTE in bladder cancer: Commentary. Oncology Report, (FALL), 24.
Armstrong, A. J. “Bevacizumab increases toxicity, VTE in bladder cancer: Commentary.” Oncology Report, no. FALL (September 1, 2009): 24.
Armstrong AJ. Bevacizumab increases toxicity, VTE in bladder cancer: Commentary. Oncology Report. 2009 Sep 1;(FALL):24.
Armstrong, A. J. “Bevacizumab increases toxicity, VTE in bladder cancer: Commentary.” Oncology Report, no. FALL, Sept. 2009, p. 24.
Armstrong AJ. Bevacizumab increases toxicity, VTE in bladder cancer: Commentary. Oncology Report. 2009 Sep 1;(FALL):24.
Published In
Oncology Report
EISSN
1548-5323
ISSN
1548-5323
Publication Date
September 1, 2009
Issue
FALL
Start / End Page
24
Related Subject Headings
- Oncology & Carcinogenesis